Repisalud
Publication
Artículo científico (JournalArticle)
Kalirin and CHD7: novel endothelial dysfunction indicators in circulating extracellular vesicles from hypertensive patients with albuminuria
Despite of the great advances in anti-hypertensive therapies, many patients under Renin-Angiotensin-System (RAS) suppression develop albuminuria, which is a clear indicator of therapeutic inefficiency. Hence, indicators of vascular function are needed to assess patients' condition and help deciding future therapies. Proteomic analysis of circulating extracellular vesicles (EVs) showed two proteins, kalirin and chromodomain-helicase-DNA-binding protein 7 (CHD7), increased in albuminuric patients. A positive correlation of both with the expression of the endothelial activation marker E-selectin was found in EVs. In vitro analysis using TNFa-treated adult human endothelial cells proved their involvement in endothelial cell activation. Hence, we propose protein levels of kalirin and CHD7 in circulating EVs as novel endothelial dysfunction markers to monitor vascular condition in hypertensive patients with albuminuria.
Project:
ES / PI07 0537
,
ES / IF08 3667-1
,
ES / PI11 02239
,
ES / PI14 0917
,
ES / PI11 01401
,
ES / PI11 02432
,
ES / PI13 01873
,
ES / PI13 01746
,
ES / PI13 01581
,
ES / PI14 01650
,
ES / PI14 01841
,
ES / PT13 0001
,
ES / PIE13 00051
,
ES / PIE13 00045
,
ES / CP09 00229
,
ES / RD06 0014
,
ES / RD12 0042